Evidence map›Paper›PMID 33530454›Full record

ReviewMicroorganisms2021

Increasing Solvent Tolerance to Improve Microbial Production of Alcohols, Terpenoids and Aromatics.

Thomas Schalck, Bram Van den Bergh, Jan Michiels

Abstract readReview
In one paragraph

Review in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Toxic Effects of Butanol in the Plane of the Cell Membrane.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas SchalckVIB Center for Microbiology, Flanders Institute for Biotechnology, B-3001 Leuven, Flemish Brabant, Belgium.ORCID 0000-0002-7796-9114
Bram Van den BerghVIB Center for Microbiology, Flanders Institute for Biotechnology, B-3001 Leuven, Flemish Brabant, Belgium.
Jan MichielsVIB Center for Microbiology, Flanders Institute for Biotechnology, B-3001 Leuven, Flemish Brabant, Belgium.

Funding

Belgian American Education Foundation (BAEF) 2016-E083European Molecular Biology Organization ALTF 344-2017Fonds Wetenschappelijk Onderzoek 12O1917NFonds Wetenschappelijk Onderzoek 1513120NFonds Wetenschappelijk Onderzoek 1528318NFonds Wetenschappelijk Onderzoek 1S14417NFonds Wetenschappelijk Onderzoek G055517NFonds Wetenschappelijk Onderzoek G0B2515NFonds Wetenschappelijk Onderzoek V428917NKU Leuven C16/17/006
6 · The paper itself

Abstract

Fuels and polymer precursors are widely used in daily life and in many industrial processes. Although these compounds are mainly derived from petrol, bacteria and yeast can produce them in an environment-friendly way. However, these molecules exhibit toxic solvent properties and reduce cell viability of the microbial producer which inevitably impedes high product titers. Hence, studying how product accumulation affects microbes and understanding how microbial adaptive responses counteract these harmful defects helps to maximize yields. Here, we specifically focus on the mode of toxicity of industry-relevant alcohols, terpenoids and aromatics and the associated stress-response mechanisms, encountered in several relevant bacterial and yeast producers. In practice, integrating heterologous defense mechanisms, overexpressing native stress responses or triggering multiple protection pathways by modifying the transcription machinery or small RNAs (sRNAs) are suitable strategies to improve solvent tolerance. Therefore, tolerance engineering, in combination with metabolic pathway optimization, shows high potential in developing superior microbial producers.

Indexed as

bacteriabioproductionfermentationproduct toxicitysolvent tolerancestress-response pathwaysyeast

Identifiers

PMID33530454
PMCPMC7912173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.